DNA methyltransferase inhibitor

5-Aza-2’-deoxycytidine (5-AzadCyD, 5-Aza-CdR, decitabine) is a specific inhibitor of DNA methylation. It functions in a similar manner to aza-citidine, although decitabine can only be incorporated into DNA strands while azacitidine can be incorporated into both DNA and RNA chains.
5-AzadCyD is a prodrug that requires activation via phosphorylation by deoxycytidine kinase. The nucleotide analog is incorporated into DNA, where it produces an irreversible inactivation of DNA methyltransferase. 5-AzadCyD was demonstrated to be a potent antineoplastic agent against leukemia and tumors in animal models [1,2].


Working concentration: 0.1-10 μM
CAS number:
Formula: C8H12N4O4
Molecular weight: 228.2
Solubility: Soluble in acetic acid:water (1:1 v/v) at 50 mg/ml


   • 10 mg or  50 mg


1. Christman JK., 2002. 5-Azacytidine and 5-aza-20-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy. Oncogene 21, 5483–5495.
2. Kulis M. & Esteller M., 2010. DNA methylation and cancer. Adv Genet. 2010;70:27-56



Description DNA methyltransferase inhibitor
Cat. Code met-adc-1
Unit Size 10 mg
Price For price or distributor address,
please select your country
Disclaimer: Our products are provided for research purposes only. Not for use in humans. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2016 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "www.invivogen.com".